NIHON KOHDEN CORPORATION (6849) Stock Price

Nihon Kohden Corporation is a corporate group engaged in the research and development, manufacturing, sales, repair, and maintenance of medical electronic equipment. As of March 31, 2025, the company owns 36 subsidiaries, comprising a total of 37 companies. Recently, Nihon Kohden Vietnam, NeuroAdvanced, Addtech, and their affiliated companies have joined the group.

Within Japan, Nihon Kohden Corporation and Nihon Kohden Tomioka handle research, development, and manufacturing of medical electronic equipment. Nihon Biotest Laboratories develops, manufactures, and sells immunochemistry products, while Benefix manufactures and sells medical information system products. E-Staff handles general affairs and staffing services, with 12 branch offices conducting sales activities.

In North America, Nihon Kohden North America manages subsidiary operations. Defibtech develops, manufactures, and sells emergency medical devices; Orangemed develops, manufactures, and sells ventilators; and Addtech develops, manufactures, and sells intracranial electrodes. Digital Health Solutions and Neurotonics conduct research and development of medical electronic equipment and software, with Nihon Kohden America handling sales.

In other regions, Shanghai Nihon Kohden Medical Electronic Instruments develops, manufactures, and sells medical electronic equipment, while Nihon Kohden Malaysia handles manufacturing, sales, and sales promotion. In India and the Middle East, the company conducts sales of medical electronic equipment and manufacturing and sales of reagents. In Florence, reagent manufacturing and sales are conducted. The software team develops and sells software for medical electronic equipment.

In Central and South America, three companies including Nihon Kohden Brazil conduct sales and sales promotion. In Europe, six companies including Nihon Kohden Europe conduct sales and sales promotion. In Asia, four companies including Nihon Kohden Singapore conduct sales and sales promotion. Additionally, Nihon Kohden Arabia RHQ, scheduled to commence operations during fiscal 2025, will handle sales in Saudi Arabia. In recent organizational restructuring, E-Staff Insurance Services was merged into E-Staff, and Amps Leading was merged into Digital Health Solutions.

Nihon Kohden Corporation is a specialized manufacturer of medical electronic equipment. Its management philosophy is to contribute to overcoming disease and promoting health through cutting-edge technology. The company prioritizes improving the soundness, transparency, and efficiency of management to enhance corporate governance and increase enterprise value.

In its medium-term management plan "BEACON 2030 Phase II," which begins in fiscal year 2024, the company has set a target consolidated ROE of 12%. The plan aims to achieve profit margins exceeding the cost of capital by shortening the cash conversion cycle and establishing investment decision criteria to meet management targets.

Nihon Kohden has formulated the long-term vision "BEACON 2030" toward 2030, targeting solutions to global healthcare challenges. The company is pursuing three key transformations: transformation into a global high-value-added company, transformation into a solution-oriented business pursuing customer value, and transformation into a global organization centered on operational excellence.

In "BEACON 2030 Phase II," the company will execute a company-wide revenue reform to strengthen growth, profitability, and capital efficiency. It will particularly focus on North American business growth, strengthening product competitiveness, and building new business models. The company is also practicing sustainability management to address healthcare, environmental, and social challenges.

By the fiscal year ending March 2027, the company targets revenue of 256 billion yen, an operating profit margin of 15%, and ROE of 12%. Through these targets, the company aims to achieve sustainable growth and enhance shareholder value.